Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:1324 (14 June), doi:10.1136/bmj.39605.462338.3A
| The first 150 words of the full text of this article appear below. |
So far the United Kingdom seems to be keeping clear of most of the international increase in drug resistant tuberculosis, in particular multidrug resistant tuberculosis (MDR-TB).1 2 But how long can this be maintained?3
The problem with drug resistant tuberculosis is that it is still relatively uncommon but gradually increasing. Individual clinicians will have very little experience in managing cases. To help this situation, the MDRTB Service has been established at the Cardiothoracic Centre in Liverpool and has been operational since 1 January 2008. The service has the support of the relevant professional bodies, including the British Thoracic Society, the British Infection Society, and the Health Protection Agency.
Essentially it is an electronically linked instant reaction expert group, who can give advice and direct management of cases across the country. It has already done so in some 17 cases from across the UK. By helping clinicians in the management of cases
Peter D O Davies, consultant physician, Damian Cullen, service coordinator
1 Cardiothoracic Centre, Liverpool L14 3PE
mdrtbservice@ctc.nhs.uk